- Home
- TXN vs LLY Comparison
TXN vs LLY Comparison
Compare TXN & LLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TXN | LLY |
|---|---|---|
| Founded | 1930 | 1876 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 160.9B | 950.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TXN | LLY |
|---|---|---|
| Price | $194.54 | $1,080.20 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 25 | 19 |
| Target Price | $202.63 | ★ $1,104.00 |
| AVG Volume (30 Days) | ★ 6.6M | 2.6M |
| Earning Date | 01-27-2026 | 02-04-2026 |
| Dividend Yield | ★ 3.00% | 0.66% |
| EPS Growth | 2.06 | ★ 121.02 |
| EPS | 5.49 | ★ 20.44 |
| Revenue | $17,266,000,000.00 | ★ $59,419,800,000.00 |
| Revenue This Year | $14.27 | $42.97 |
| Revenue Next Year | $7.98 | $21.50 |
| P/E Ratio | ★ $34.54 | $50.94 |
| Revenue Growth | 9.90 | ★ 45.41 |
| 52 Week Low | $139.95 | $623.78 |
| 52 Week High | $221.69 | $1,133.95 |
Technical Indicators
Market Signals| Indicator | TXN | LLY |
|---|---|---|
| Relative Strength Index (RSI) | 63.64 | 55.89 |
| Support Level | $187.95 | $1,015.96 |
| Resistance Level | $196.64 | $1,090.22 |
| Average True Range (ATR) | 5.17 | 34.87 |
| MACD | 0.54 | -5.08 |
| Stochastic Oscillator | 90.95 | 55.71 |
Price Performance
Historical ComparisonAbout TXN Texas Instruments Incorporated
Dallas-based Texas Instruments generates over 95% of its revenue from semiconductors and the remainder from its well-known calculators. Texas Instruments is the world's largest maker of analog chips, which are used to process real-world signals such as sound and power. Texas Instruments also has a leading market share position in processors and microcontrollers used in a wide variety of electronics applications.
About LLY Eli Lilly and Company
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.